Figure 1
Figure 1. TBT. The TBT was measured 2 months post-BM grafting in WT and VavCre/JAK2V617F KI mice (A, n = 8) and at different times after administration of tamoxifen (TM, n = 8) or vehicle (VH, n = 22) in SCLCreERt/JAK2V617F KI mice (B). The arrow at 15 minutes indicates that bleeding was arrested by the experimenter. Each point represents an individual mouse. The volume of blood lost in 15 minutes was measured in VavCre/JAK2V617F KI (Aii) and in SCLCreERt/JAK2V617F KI mice (Bii). (C) The frequency of transient bleeding arrests observed in SCLCreERt/JAK2V617F KI mice at different times after administration of tamoxifen was quantified. *P < .05; **P < .004; ***P < .0001.

TBT. The TBT was measured 2 months post-BM grafting in WT and VavCre/JAK2V617F KI mice (A, n = 8) and at different times after administration of tamoxifen (TM, n = 8) or vehicle (VH, n = 22) in SCLCreERt/JAK2V617F KI mice (B). The arrow at 15 minutes indicates that bleeding was arrested by the experimenter. Each point represents an individual mouse. The volume of blood lost in 15 minutes was measured in VavCre/JAK2V617F KI (Aii) and in SCLCreERt/JAK2V617F KI mice (Bii). (C) The frequency of transient bleeding arrests observed in SCLCreERt/JAK2V617F KI mice at different times after administration of tamoxifen was quantified. *P < .05; **P < .004; ***P < .0001.

Close Modal

or Create an Account

Close Modal
Close Modal